Get the Stockscreener App
5.22
0.95%
-0.05
After Hours:
5.21
-0.010
-0.19%
Myomo Inc stock is traded at $5.22, with a volume of 186.59K.
It is down -0.95% in the last 24 hours and up +38.83% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$5.27
Open:
$5.25
24h Volume:
186.59K
Relative Volume:
1.17
Market Cap:
$159.40M
Revenue:
$25.24M
Net Income/Loss:
$-8.38M
P/E Ratio:
-6.2143
EPS:
-0.84
Net Cash Flow:
$-9.54M
1W Performance:
+6.10%
1M Performance:
+38.83%
6M Performance:
+36.29%
1Y Performance:
+55.82%
1-Day Range:
$5.0812
$5.39
1-Week Range:
$4.685
$5.39
52-Week Range:
$2.5108
$5.64
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
5.22 | 159.40M | 25.24M | -8.38M | -9.54M | -0.84 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Myomo (STU:0M61) Forward Dividend Yield % : 0.00% (As of Nov. 25, 2024) - GuruFocus.com
HC Wainwright Issues Pessimistic Estimate for Myomo Earnings - MarketBeat
What is HC Wainwright's Estimate for Myomo FY2028 Earnings? - MarketBeat
Myomo (NYSEAMERICAN:MYO) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says - Defense World
Myomo (NYSEAMERICAN:MYO) Price Target Raised to $9.00 - MarketBeat
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates - MSN
Earnings call: Myomo reports record Q3 revenue, eyes future growth - Investing.com India
Earnings call: Myomo reports record Q3 revenue, eyes future growth By Investing.com - Investing.com South Africa
Myomo revenue jumps 81% in Q3 2024 - Medical Buyer
Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus.com
Myomo, Inc. Reports Record Third Quarter Growth - TipRanks
Myomo Inc Reports Record Q3 2024 Earnings: Revenue Hits $9.2M, E - GuruFocus.com
Myomo Q3 Revenue Surges 81% to Record $9.2M, Raises Full-Year Guidance | MYO Stock News - StockTitan
Rosalind Advisors Inc. Buys 356,392 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
CMS Decision And O&P Network Build out Make Myomo A Buy (MYO) - Seeking Alpha
Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Ea - GuruFocus.com
Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage - Tech Funding News
Extended Session Rally For Myomo (MYO) Stock - Stocks Telegraph
Myomo to Report Third Quarter Financial Results on November 6, 2024 - The Bakersfield Californian
Rosalind Advisors, Inc. Expands Stake in Myomo Inc - GuruFocus.com
Myomo, Inc. (NYSEAMERICAN:MYO) Shares Bought by Essex Investment Management Co. LLC - MarketBeat
Renaissance Technologies LLC Sells 146,616 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit - 01Net
Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... - Yahoo Finance
Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion Plans - GuruFocus.com
Myomo, Inc. (NYSEAMERICAN:MYO) Shares Acquired by Herr Investment Group LLC - MarketBeat
Stocks of Moelis & Co (MC) are poised to climb above their peers - SETE News
MBX Biosciences director buys $12 million in company stock By Investing.com - Investing.com South Africa
OrbiMed executives purchase $12 million of MBX Biosciences stock - Investing.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AGMYNA - PR Newswire
Kenya’s Most Funded Fintech M-Kopa Fined KSh 885.87 Million in Taxes in Jurisdiction Dispute - Kenyan Wallstreet
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly - Business Wire
Robotics for Physical Therapy Market 2024 Key Vendors – AlterG, Bionik, Ekso Bionics, Myomo - Cauverynews
Medical Wearable Robotic Market 2024 Industry Scenario – Bionik, Ekso Bionics, Myomo, Hocoma - Cauverynews
Myomo executive sells over $8k in company stock - Investing.com
Myomo to Participate in Two Investor Conferences in September - Business Wire
Myomo executive sells over $8k in company stock By Investing.com - Investing.com Canada
Myomo Inc [MYO] Officer makes an insider purchase of 139 shares worth 541.0. - Knox Daily
Analyzing Myomo Inc (MYO) After Recent Trading Activity - Knox Daily
Myomo (MYO) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Myomo: Intriguing Prospects, But Preferable To Wait For A Further Pullback In The Price - Seeking Alpha
Ascendiant Capital Markets Boosts Myomo (NYSEAMERICAN:MYO) Price Target to $8.50 - MarketBeat
Ascendiant Capital Markets Raises Myomo (NYSEAMERICAN:MYO) Price Target to $8.50 - Defense World
The Analyst Verdict: Myomo In The Eyes Of 4 Experts - Benzinga
Myomo (MYO) 3-Year EBITDA Growth Rate : 57.00% (As of Jun. 2024) - GuruFocus.com
Q3 2024 Earnings Forecast for Myomo, Inc. (NYSEAMERICAN:MYO) Issued By HC Wainwright - MarketBeat
Myomo Inc (MYO) rating initates by Craig Hallum - Knox Daily
HC Wainwright Analysts Boost Earnings Estimates for Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
Q4 2024 EPS Estimates for Myomo, Inc. Boosted by Analyst (NYSEAMERICAN:MYO) - Defense World
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):